Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Erlanson

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Circulation|July 5, 2013
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginineYohannes T Ghebremariam, Paea LePendu, Jerry C Lee, et al.
Journal of the American Chemical Society|May 8, 2003
Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tetheringDaniel A Erlanson, Robert S McDowell, Molly M He, et al.
Circulation|April 2, 2014
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine"Yohannes T Ghebremariam, Jerry C Lee, Paea LePendu, et al.
Nature Communications|May 5, 2025
Where and how to house big data on small fragmentsDaniel A Erlanson, Stephen K Burley, Daren Fearon, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|November 25, 2025
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual PerspectiveDavid G Twigg, Kenta Arai, Michelle R Arkin, et al.
Journal of Medicinal Chemistry|January 13, 2026
Correction to "Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective"David G Twigg, Kenta Arai, Michelle R Arkin, et al.
Nature Structural & Molecular Biology|July 20, 2004
Allosteric inhibition of protein tyrosine phosphatase 1BChristian Wiesmann, Kenneth J Barr, Jenny Kung, et al.
Nature Biotechnology|February 4, 2003
In situ assembly of enzyme inhibitors using extended tetheringDaniel A Erlanson, Joni W Lam, Christian Wiesmann, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Circulation|July 5, 2013
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginineYohannes T Ghebremariam, Paea LePendu, Jerry C Lee, et al.
Journal of the American Chemical Society|May 8, 2003
Discovery of a new phosphotyrosine mimetic for PTP1B using breakaway tetheringDaniel A Erlanson, Robert S McDowell, Molly M He, et al.
Circulation|April 2, 2014
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine"Yohannes T Ghebremariam, Jerry C Lee, Paea LePendu, et al.
Nature Communications|May 5, 2025
Where and how to house big data on small fragmentsDaniel A Erlanson, Stephen K Burley, Daren Fearon, et al.
ACS Medicinal Chemistry Letters|June 20, 2014
Validity of ligand efficiency metricsChristopher W Murray, Daniel A Erlanson, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|November 25, 2025
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual PerspectiveDavid G Twigg, Kenta Arai, Michelle R Arkin, et al.
Journal of Medicinal Chemistry|January 13, 2026
Correction to "Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective"David G Twigg, Kenta Arai, Michelle R Arkin, et al.
Nature Structural & Molecular Biology|July 20, 2004
Allosteric inhibition of protein tyrosine phosphatase 1BChristian Wiesmann, Kenneth J Barr, Jenny Kung, et al.
Nature Biotechnology|February 4, 2003
In situ assembly of enzyme inhibitors using extended tetheringDaniel A Erlanson, Joni W Lam, Christian Wiesmann, et al.
Structure (London, England : 1993)|October 4, 2025
Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradationEvan J McMahon, Alexander G Cioffi, Patrick R Visperas, et al.
Pageof 5